183 related articles for article (PubMed ID: 18057279)
21. Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization.
Artinyan A; Guzman E; Maghami E; Al-Sayed M; D'Apuzzo M; Wagman L; Kim J
J Clin Oncol; 2008 Aug; 26(24):4039-41. PubMed ID: 18711197
[No Abstract] [Full Text] [Related]
22. Interventional oncology in the abdomen.
Gervais DA
Abdom Imaging; 2009; 34(5):545-6. PubMed ID: 18987908
[No Abstract] [Full Text] [Related]
23. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?
Forner A; Ayuso C; Varela M; Rimola J; Hessheimer AJ; de Lope CR; Reig M; Bianchi L; Llovet JM; Bruix J
Cancer; 2009 Feb; 115(3):616-23. PubMed ID: 19117042
[TBL] [Abstract][Full Text] [Related]
24. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
[TBL] [Abstract][Full Text] [Related]
25. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
26. Chemoembolization of hepatic malignancy.
Gonsalves CF; Brown DB
Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
[TBL] [Abstract][Full Text] [Related]
27. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal stromal tumor: role of interventional radiology in diagnosis and treatment.
Avritscher R; Gupta S
Hematol Oncol Clin North Am; 2009 Feb; 23(1):129-37, ix. PubMed ID: 19248976
[TBL] [Abstract][Full Text] [Related]
29. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
30. Re: Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors.
Wright KC
J Vasc Interv Radiol; 2009 Jun; 20(6):851-2; author reply 852-3. PubMed ID: 19465311
[No Abstract] [Full Text] [Related]
31. [Minimally invasive tumor ablation in the liver].
Wybranski C; Mohnike K; Ricke J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Oct; 44(10):670-7; quiz 679. PubMed ID: 19834832
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous image-guided radiofrequency ablation of liver tumors.
Lencioni R; Crocetti L; Pina MC; Cioni D
Abdom Imaging; 2009; 34(5):547-56. PubMed ID: 19030918
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous biopsy before interventional oncologic therapy: current status.
Brown DB; Gonsalves CF
J Vasc Interv Radiol; 2008 Jul; 19(7):973-9. PubMed ID: 18589310
[No Abstract] [Full Text] [Related]
34. Terminology and reporting criteria for radiofrequency ablation of tumors in the scientific literature: systematic review of compliance with reporting standards.
Kang TW; Rhim H; Lee MW; Kim YS; Choi D; Lim HK
Korean J Radiol; 2014; 15(1):95-107. PubMed ID: 24497798
[TBL] [Abstract][Full Text] [Related]
35. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma: latest developments.
Walzer N; Kulik LM
Curr Opin Gastroenterol; 2008 May; 24(3):312-9. PubMed ID: 18408459
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation of the liver: how do we do it.
Vandenbroucke F; Ilsen B; Craggs B; Op de Beeck B; de Mey J
JBR-BTR; 2007; 90(6):490-1. PubMed ID: 18376762
[TBL] [Abstract][Full Text] [Related]
38. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
39. Management of hepatic metastasis from colorectal cancers: an update.
Sharma S; Camci C; Jabbour N
J Hepatobiliary Pancreat Surg; 2008; 15(6):570-80. PubMed ID: 18987925
[TBL] [Abstract][Full Text] [Related]
40. Analysis of nontarget embolization mechanisms during embolization and chemoembolization procedures.
López-Benítez R; Richter GM; Kauczor HU; Stampfl S; Kladeck J; Radeleff BA; Neukamm M; Hallscheidt PJ
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):615-22. PubMed ID: 19387732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
